We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+14.36%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.63B
AUM Growth
+$146M
Cap. Flow
-$6.24M
Cap. Flow %
-0.38%
Top 10 Hldgs %
44.09%
Holding
1,031
New
130
Increased
362
Reduced
253
Closed
186

Sector Composition

Rank Sector Weight
1 Technology 25.9%
2 Financials 17.27%
3 Communication Services 9.63%
4 Industrials 9.11%
5 Consumer Discretionary 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WST icon
751
West Pharmaceutical
WST
$24.4B
$3.72K ﹤0.01%
17
-628
-97% -$134K
MRP
752
Millrose Properties Inc
MRP
$4.77B
$3.68K ﹤0.01%
129
+77
+148% +$2.04K
EXPD icon
753
Expeditors International
EXPD
$23.2B
$3.66K ﹤0.01%
32
-49
-60% -$5.49K
TSN icon
754
Tyson Foods
TSN
$20.7B
$3.64K ﹤0.01%
+65
New +$3.74K
PNR icon
755
Pentair
PNR
$11.2B
$3.59K ﹤0.01%
35
-66
-65% -$6.16K
PFGC icon
756
Performance Food Group
PFGC
$17.9B
$3.59K ﹤0.01%
+41
New +$3.41K
SSNC icon
757
SS&C Technologies
SSNC
$18.7B
$3.56K ﹤0.01%
43
-62
-59% -$4.87K
J icon
758
Jacobs Solutions
J
$16.8B
$3.55K ﹤0.01%
27
-39
-59% -$4.81K
HOLX
759
DELISTED
Hologic
HOLX
$3.45K ﹤0.01%
+53
New +$3.18K
FTV icon
760
Fortive
FTV
$18.6B
$3.44K ﹤0.01%
66
-176
-73% -$9.22K
LII icon
761
Lennox International
LII
$15.3B
$3.44K ﹤0.01%
6
-10
-63% -$5.59K
NBIX icon
762
Neurocrine Biosciences
NBIX
$16.3B
$3.39K ﹤0.01%
27
+3
+13% +$344
DLTR icon
763
Dollar Tree
DLTR
$24.8B
$3.37K ﹤0.01%
34
-4,436
-99% -$383K
TNC icon
764
Tennant Co
TNC
$1.24B
$3.33K ﹤0.01%
+43
New +$3.18K
NE icon
765
Noble Corp
NE
$6.56B
$3.32K ﹤0.01%
125
-4
-3% -$96
LDOS icon
766
Leidos
LDOS
$16.9B
$3.31K ﹤0.01%
21
-7,599
-100% -$1.12M
RBA icon
767
RB Global
RBA
$17.3B
$3.29K ﹤0.01%
31
-50
-62% -$5.13K
TXT icon
768
Textron
TXT
$15.1B
$3.29K ﹤0.01%
+41
New +$2.97K
HQY icon
769
HealthEquity
HQY
$8.72B
$3.25K ﹤0.01%
+31
New +$2.94K
JAZZ icon
770
Jazz Pharmaceuticals
JAZZ
$16.8B
$3.18K ﹤0.01%
+30
New +$3.26K
GRC icon
771
Gorman-Rupp
GRC
$2.23B
$3.16K ﹤0.01%
+86
New +$3.09K
EXEL icon
772
Exelixis
EXEL
$13.1B
$3.13K ﹤0.01%
71
+2
+3% +$80
TRU icon
773
TransUnion
TRU
$15B
$3.08K ﹤0.01%
35
-71
-67% -$5.92K
MRTN icon
774
Marten Transport
MRTN
$1.21B
$3.05K ﹤0.01%
+235
New +$3.1K
CLH icon
775
Clean Harbors
CLH
$16.4B
$3K ﹤0.01%
13
-24
-65% -$5.25K

Similar funds

Meeder Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Meeder Asset Management held 1,031 positions worth $1.63B, up 9.9% from $1.48B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Meeder Asset Management's Q2 2025 filing shows 130 new, 362 increased, 253 reduced and 186 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 687,194 shares worth $65.8M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Financials and Communication Services.

  • Meeder Asset Management's largest Q2 2025 buy was iShares 7-10 Year Treasury Bond ETF: 687,194 shares worth $65.8M.
  • Meeder Asset Management added most to Ametek in Q2 2025, an estimated $13.5M increase.
  • Meeder Asset Management's biggest Q2 2025 reduction was Apple, cutting an estimated $34.6M.
  • Meeder Asset Management fully exited iShares 20+ Year Treasury Bond ETF in Q2 2025, selling an estimated $68.6M.
  • Meeder Asset Management's ten largest holdings make up 44% of its $1.63B portfolio in Q2 2025.
  • Meeder Asset Management opened 130 new positions and closed 186 in Q2 2025.
  • Meeder Asset Management's portfolio value rose 9.9% quarter-over-quarter to $1.63B.

Based on Meeder Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.